Body-contouring treatments are measured on a different outcome from the one most people think they are buying. The pooled trial evidence for cryolipolysis — the cold-based fat-reduction devices — reports a reduction in the thickness of the fat layer at the treated site and in the circumference of that area, alongside a body-weight result that was not statistically significant: a mean difference of −1.81 kg, 95% CI −3.93 to 0.31, P=0.09 (Hakami 2025). Those two findings sit in the same meta-analysis. Understanding why they can both be true is the whole subject of this article.

Both of those findings are real. These are localised procedures evaluated on localised measures, and moving a local measure is what they are built to do. The error runs in both directions: a fat-thickness figure does not carry a weight-loss claim, and a non-significant weight result does not mean the device did nothing.

Fat-layer thickness: how deep the layer of fat is at one measured spot, read by ultrasound or callipers. Body fat: the total quantity of fat tissue in the whole body, estimated by a scan. They are different quantities in different units, and a change in one does not imply a change in the other.

What the cryolipolysis trials actually measured

A 2025 systematic review and meta-analysis pooled randomised trials and prospective cohorts of cryolipolysis and reported four outcomes. Fat thickness fell (mean difference −3.56, 95% CI −4.63 to −2.48, P<0.00001). Circumference at various treated body parts fell (−3.45, 95% CI −5.55 to −1.34, P=0.001). BMI fell (−1.71, 95% CI −2.6 to −0.82, P=0.0002). Body weight did not change significantly (−1.81 kg, 95% CI −3.93 to 0.31, P=0.09), and the authors state the treatment "does not significantly affect overall weight" (Hakami 2025).

Every figure above is a pooled mean across trial populations, and individual results vary. Two further things about that analysis deserve to be read alongside the numbers. Heterogeneity was very high — I²=92% for circumference and I²=95% for fat thickness — meaning the included studies disagreed substantially with one another, so the pooled estimate is an average across trials that were not measuring the same thing in the same way. And the study count and total participant number were not retrievable from the record available, so no sample size is quoted here.

The BMI result is worth pausing on, because BMI is computed from weight and height. A BMI reduction of 1.71 alongside a non-significant weight change is internally odd, and it is one more reason to read the fat-thickness and circumference results as the primary findings and to treat everything else in that analysis as uncertain.

What the ultrasound reviews measured

High-intensity focused ultrasound (HIFU) body contouring has a 2025 systematic review of 45 clinical trials and cohort studies published between 2010 and 2024. For body contouring it reports circumference reduction of 2.5 to 4.5 cm, mostly at the abdomen, flanks and thighs, with waist circumference falling around 3 cm. Skin laxity improved 18 to 30%. Adverse events occurred in fewer than 5% and were transient — erythema, swelling, mild discomfort (Haykal 2025).

No weight outcome and no total-fat outcome appears anywhere in that review. The measures are circumference and skin. The authors themselves flag that "standardization of treatment protocols remains a key challenge", that "operator skill and experience are critical factors", that long-term efficacy beyond 12 months has not been established, and that data in darker skin types is limited. The included studies are predominantly prospective and retrospective clinical cohorts rather than randomised trials, which is a weaker design for attributing a change to a treatment.

Why a thinner fat layer in one place is not less body fat

Body fat is distributed across many depots. When total body fat falls, those depots fall together, and no method has been shown to pick one.

Pooling 89 studies across diet and exercise, weight-loss medication and bariatric surgery, the percentage reduction in visceral fat consistently exceeded the percentage reduction in subcutaneous fat — while the absolute reduction was larger in subcutaneous fat, because that depot is larger to begin with. The review's own conclusion is unambiguous: "No intervention preferentially targets visceral fat" (Merlotti 2017). A separate systematic review across 61 studies and 98 cohort time points found that the only variable influencing the ratio of visceral to subcutaneous fat loss was the size of the weight loss itself (r=−0.29, P=0.005), and that the method of losing weight was not an influence (Chaston 2008).

The relevance here is directional rather than exact — those reviews studied weight-loss interventions, not devices. But they establish the background fact a local measurement sits against: where fat comes off is a function of how much comes off, not of where a treatment is applied. A smaller fat layer in one treated area, measured at that area, is a local result. It is a real result, and it is a local one.

How Singapore regulates these treatments

Two separate regimes touch this, and neither one is a statement about whether a treatment works.

The Singapore Medical Council's Guidelines on Aesthetic Practices for Doctors list "External Lipolysis (Heat / Cold / Ultrasound)" in Table 1, as a non-invasive aesthetic procedure that may be performed in a clinic by doctors who meet defined training requirements (SMC 2016). Being listed governs who may perform a procedure and where — it is not an endorsement that the procedure is effective. The same guidelines require, verbatim, that "Doctors must ensure that the content of any advertisements (especially images) and how aesthetic procedures are described are not misleading", and they record that MOH withdrew a separate category of aesthetic procedures in 2015 after a review found their results "largely equivocal and inconclusive". Those withdrawn procedures were mesotherapy and carboxytherapy, not the lipolysis devices discussed here.

HSA regulates medical devices by risk class and requires registration before sale, except for the lowest-risk class A. Its own guidance carries an exclusion that matters for this category: "Products used for general well-being, such as body toning equipment, magnetic accessories and massagers, are not medical devices" (HSA 2026). Whether a given machine falls inside HSA's remit therefore turns on its stated purpose and effect. Whether any particular device is registered is a question for HSA's medical device register, and nothing here should be read as a statement about any specific product.

How to read a claim about a body-contouring treatment

One question does most of the work: which outcome was measured, and over what area?

  • A centimetre figure is a circumference at a site. It answers how a garment fits at that site.
  • A millimetre or "fat thickness" figure is the depth of the fat layer under a probe at one spot.
  • A kilogram figure is body weight, which the cryolipolysis meta-analysis found did not change significantly.
  • A percentage body fat figure is a whole-body estimate from a scan, and is not among the outcomes reported in either review above.

These are four different quantities. A treatment can move the first two without moving the last two, and the published evidence for these devices is precisely that pattern.

The second question is what the treatment was compared against. Most of the HIFU literature is uncontrolled cohorts, where every participant received the treatment and there is no untreated comparison group (Haykal 2025). Without a comparison group, an observed change cannot be separated from what would have happened anyway.

The third is how long the measurement was held. The HIFU review's authors state directly that "further research is needed to establish its long-term efficacy" beyond 12 months, so nothing in it speaks to whether a circumference reduction is still present at two years (Haykal 2025). The cryolipolysis analysis reports no follow-up horizon at all in the record available. A figure with no duration attached is a snapshot, and a snapshot cannot distinguish a durable change from a temporary one.

The fourth is how much the studies agreed with one another. Heterogeneity in the cryolipolysis pooling ran at I²=92% for circumference and I²=95% for fat thickness (Hakami 2025) — a level at which the pooled mean is a summary of studies that disagreed, rather than a consistent finding reproduced across them. The number that gets quoted from a meta-analysis is the average; the heterogeneity statistic is how much confidence that average deserves, and it is almost never quoted alongside it.

Where this sits next to a medical weight-management pathway

The two are measured on different things, and that is the cleanest way to hold them apart. A localised device is evaluated on fat-layer thickness and circumference at a treated area. A weight-management programme is evaluated on body weight, and — where anyone bothers to measure it — on the split between fat mass and lean mass across the whole body.

At GetLean, our position is that the second measurement is the one worth organising a plan around, because the number on a scan tells you what a loss was made of and a tape measure at one site does not. That is our view, not a finding about anyone else's service. If you want to know what a whole-body measurement would show for you, and whether a medical pathway is suitable, you can check your eligibility and put the question to a doctor.

Common questions

Does cryolipolysis make you lose weight?

Not measurably. The pooled trial evidence reports reduced fat-layer thickness (mean difference −3.56) and reduced circumference at the treated area (−3.45), alongside a body-weight result that was not statistically significant: −1.81 kg, 95% CI −3.93 to 0.31, P=0.09 (Hakami 2025). The same meta-analysis reports both findings, and the authors state the treatment does not significantly affect overall weight.

Is a thinner fat layer at the treated area the same as having less body fat?

No. Fat-layer thickness is a measurement at one site with an ultrasound probe or calliper; body fat is a whole-body quantity estimated by a scan. A treatment can move the first without moving the second, which is what the cryolipolysis meta-analysis found when it reported reduced fat thickness and no significant weight change in the same analysis (Hakami 2025).

What does HIFU body contouring actually reduce?

Circumference at the treated area. A systematic review of 45 studies reported reductions of about 2.5 to 4.5 cm, mostly at the abdomen, flanks and thighs, with waist circumference falling around 3 cm (Haykal 2025). No weight outcome and no total-fat outcome is reported anywhere in that review, and most of the included studies were uncontrolled cohorts rather than randomised trials.

Can any treatment target fat in one specific area?

Pooling 89 studies across diet, exercise, weight-loss medication and surgery, no intervention preferentially targeted one fat depot over another (Merlotti 2017). A separate review of 61 studies found the only variable predicting where fat came off was how much weight was lost overall, with the method making no difference (Chaston 2008).

Are body-contouring machines regulated in Singapore?

It depends on what the device claims to do. HSA registers medical devices by risk class before sale, but its own guidance places general well-being products such as body-toning equipment outside the medical-device definition altogether (HSA 2026). Separately, the Singapore Medical Council lists external lipolysis by heat, cold or ultrasound as a non-invasive aesthetic procedure with defined training requirements for the doctors who perform it (SMC 2016).